Panel Gives OSI Thumbs Up for New Tarceva Indication

Drug Industry Daily
KEYWORDS FDA / NDA
A A

A panel of FDA oncology advisers has endorsed giving OSI Pharmaceuticals a new indication for its cancer treatment Tarceva.

To View This Article:

Login

Subscribe To Drug Industry Daily